The interplay between microbiota and inflammation: lessons from peritonitis and sepsis

Clinical and Translational Immunology

Volumn 5, Issue 7, 2016, Pages

  Lobo, Leandro A ^a   Benjamim, Claudia F ^a   Oliveira, Ana Carolina ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85031846316     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/CTI.2016.32     Document Type: Review

References (82)

1. Rooijers K, Kolmeder C, Juste C, Doré J, De been M, Boeren S et al. An iterative workflow for mining the human intestinal metaproteome. BMC Genomics 2011; 12: 1–11.
2. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology—Human gut microbes associated with obesity. Nature 2006; 444: 1022–1023.
3. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK et al. Gut Microbiota in human adults with type 2 diabetes differs from nondiabetic adults. PLoS One 2010; 5: e9085.
4. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesityassociated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027–1031.
5. Ellekilde M, Selfjord E, Larsen CS, Jakesevic M, Rune I, Tranberg B et al. Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice. Sci Rep 2014; 4: 5922–5999.
6. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214.
7. McKenney PT, Pamer EG. From hype to hope: the gut microbiota in enteric infectious disease. Cell 2015; 163: 1326–1332.
8. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1: 113–118.
9. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107–118.
10. Maynard CL, Weaver CT. Intestinal effector T cells in health and disease. Immunity 2009; 31: 389–400.
11. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 2007; 19: 59–69.
12. Corthay A. How do regulatory T cells work? Scand J Immunol. 2009; 70: 326–336.
13. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337–341.
14. O’Mahony C, Scully P, O’Mahony D, Murphy S, O’Brien F, Lyons A et al. Commensal-induced regulatory T cells mediate protection against pathogenstimulated NFkappaB activation. PLoS Pathog 2008; 4: e1000112.
15. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620–625.
16. Kawamoto S, Maruya M, Kato LM, Suda W, Atarashi K, Doi Y et al. Foxp3(+) T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 2014; 41: 152–165.
17. Cebula A, Seweryn M, Rempala GA, Pabla SS, McIndoe RA, Denning TL et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013; 497: 258–262.
18. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485–498.
19. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145: 745–757.
20. Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014; 158: 1000–1010.
21. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159–166.
22. Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and ‘Western-lifestyle’ inflammatory diseases. Immunity 2014; 40: 833–842.
23. Tan J, McKenzie CI, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol 2014; 121: 91–119.
24. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282–1286.
25. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451–455.
26. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569–573.
27. Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 2015; 6: 6734–6748.
28. McKenzie CI, Mackay CR, Macia L. GPR43-a prototypic metabolite sensor linking metabolic and inflammatory diseases. Trends Endocrinol Metab 2015; 26: 511–512.
29. Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, Mason LJ et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun 2015; 6: 7320–7332.
30. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014; 111: 2247–2252.
31. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate suppresses colonic inflammation and carcinogenesis. Immunity 2014; 40: 128–139.
32. Patrick S, Blakely GW, Houston S, Moore J, Abratt VR, Bertalan M et al. Twenty-eight divergent polysaccharide loci specifying within-and amongst-strain capsule diversity in three strains of Bacteroides fragilis. Microbiology 2010; 156: 3255–3269.
33. Coyne MJ, Weinacht KG, Krinos CM, Comstock LE. Mpi recombinase globally modulates the surface architecture of a human commensal bacterium. Proc Natl Acad Sci USA 2003; 100: 10446–10451.
34. Tzianabos AO, Onderdonk AB, Smith RS, Kasper DL. Structure-function relationships for polysaccharide-induced intra-abdominal abscesses. Infect Immun 1994; 62: 3590–3593.
35. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010; 107: 12204–12209.
36. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA et al. The Toll-like receptor 2 pathway establishes colonisation by a commensal of the human microbiota. Science 2011; 332: 974–977.
37. Telesford KM, Yan W, Ochoa-Reparaz J, Pant A, Kircher C, Christy MA et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 2015; 6: 234–242.
38. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257–1265.
39. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010; 185: 4101–4108.
40. Wang Y, Telesford KM, Ochoa-Repáraz J, Haque-Begum S, Christy M, Kasper EJ et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signaling. Nat Commun 2014; 5: 1–10.
41. Wang Y, Begum-Haque S, Telesford KM, Ochoa-Repáraz J, Christy M, Kasper EJ et al. A commensal bacterial product elicits and modulates migratory capacity of CD39(+) CD4 T regulatory subsets in the suppression of neuroinflammation. Gut Microbes 2014; 5: 552–561.
42. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell 2004; 117: 677–687.
43. Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med 2006; 203: 2853–2863.
44. Surana NK, Kasper DL. The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol Rev 2012; 245: 13–26.
45. Hadley GP. Intra-abdominal sepsis–epidemiology, aetiology and management. Semin Pediatr Surg 2014; 23: 357–362.
46. Weledji EP, Ngowe MN. The challenge of intra-abdominal sepsis. Int J Surg 2013; 11: 290–295.
47. Finegold SM, Wexler HM. Present studies of therapy for anaerobic infections. Clin Infect Dis 1996; 23 (Suppl 1): S9–S14.
48. Onderdonk AB, Weinstein WM, Sullivan NM, Bartlett JG, Gorbach SL. Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun 1974; 10: 1256–1259.
49. Brook I. The role of anaerobic bacteria in bacteremia. Anaerobe 2010; 16: 183–189.
50. Polk BF, Kasper DL. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med 1977; 86: 569–571.
51. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, Comstock LE. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 2001; 414: 555–558.
52. Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis 1977; 136: 82–89.
53. Shapiro ME, Kasper DL, Zaleznik DF, Spriggs S, Onderdonk AB, Finberg RW. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol 1986; 137: 341–346.
54. Duan J, Avci FA, Kasper DL. Microbial carbohydrate depolymerization by antigenpresenting cells: deamination prior to presentation by the MHCII pathway. Proc Natl Acad Sci USA 2008; 105: 5183–5188.
55. Cobb BA, Kasper DL. Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology 2008; 18: 707–718.
56. + T-cell activation via the CD28–B7-2 costimulatory pathway. Infect Immun 2000; 68: 6650–6655.
57. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med 1982; 155: 1188–1197.
58. Gibson FC 3rd, Onderdonk AB, Kasper DL, Tzianabos AO. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol 1998; 160: 5000–5006.
59. Alhawi M, Stewart J, Erridge C, Patrick S, Poxton IR. Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. J Med Microbiol 2009; 58: 1015–1022.
60. Kim TH, Lee KB, Kang MJ, Park JH. Critical role of Toll-like receptor 2 in Bacteroides fragilis-mediated immune responses in murine peritoneal mesothelial cells. Microbiol Immunol 2012; 56: 782–788.
61. Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 2004; 53: 735–740.
62. Finlay-Jones JJ, Davies KV, Sturm LP, Kenny PA, Hart PH. Inflammatory processes in a murine model of intra-abdominal abscess formation. J Leukoc Biol 1999; 66: 583–587.
63. Nulsen MF, Finlay-Jones JJ, Skinner JM, McDonald PJ. Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents. Br J Exp Pathol 1983; 64: 345–353.
64. Angus DC, van der Poll T. Severe sepsis and septic shock. New Engl J Med 2013; 369: 840–851.
65. Júnior JALS, David CM, Hatum R, Souza PCSP, Japiassú A, Pinheiro CTS et al. An Epidemiological Study of Sepsis in Intense Care Units. Sepsis Brazil Study. Rev Bras Ter Intensiva 2006; 18: 9–17.
66. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481–1483.
67. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al. 2001 SCCM/ESICM/ACCP/ATS/SIS Inter-national Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–1256.
68. Valdés-Ferrer SI. The challenges of long-term sepsis survivors: when surviving is just the beginning. Rev Invest Clín 2014; 66: 439–449.
69. Perl T, Dvorak L, Hwang T, Wenzel R. Long-term survival and function after suspected Gram-negative sepsis. JAMA 1995; 274: 338–345.
70. Iwashyna TJ. Survivorship will be the defining challenge of critical care in the 21st century. Ann Intern Med 2010; 153: 204–205.
71. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546–1554.
72. Williams TA, Dobb GJ, Finn JC, Knuiman MW, Geelhoed E, Lee KY et al. Determinants of long-term survival after intensive care. Crit Care Med 2008; 36: 1523–1530.
73. Dickson R. The microbioma and critical illness. Lancet Respir Med 2016; 4: 59–72.
74. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010; 330: 1768–1773.
75. Deshmukh HS, Liu Y, Menkiti OR, Mei J, Dai N, O’Leary CE et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014; 20: 524–530.
76. Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. mBio 2014; 5: e01361–14.
77. Defazio J, Fleming I, Shakhsheer B, Zaborina O, Alverdy J. The opposing forces of the intestinal microbiome and the emerging pathobiome. Surg Clin North Am 2014; 94: 1151–1161.
78. Benjamim CF, Lundy SK, Lukacs NW, Hogaboam CM, Kunkel SL. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 2005; 105: 3588–3595.
79. Molinaro R, Pecli C, Guilherme RF, Alves-Filho JC, Cunha FQ, Canetti C et al. CCR4 controls the suppressive effects of regulatory T cells on early and late events during severe sepsis. Plos One 2015; 10: e0133227.
80. Arraes SMA, Freitas MS, Silva SV, Paula Neto HE, Alves-Filho JC, Martins MA et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorilation. Blood 2006; 108: 2906–2913.
81. Li Q, Wang C, Tang C, He Q, Zhao X, Li N et al. Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report. Crit Care 2015; 19: 37.
82. Singh S, Jing E, Stollman N. Self-limited sepsis syndrome following fecal microbiota therapy for refractory C. difficile infection. Dig Dis Sci, published online 05 November 2015; pp 1–4.